Drug-labels.com

Potassium Chloride for Injection Concentrate Product Monograph

Strength:
20 mEq
Active ingredient:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Product Monograph - Potassium Chloride for Injection Concentrate

Adverse effects

Nausea, vomiting, diarrhea and abdominal discomfort have been reported. The symptoms and signs of potassium intoxication include paresthesias of the extremities, flaccid

Concentrate - must be diluted before use

For management of a suspected drug overdose, contact your regional poison control centre.

Paralysis, fitlessness, mental confusion, weakness and heaviness of the legs, fall in blood pressure, cardiac arrhythmias and heart block. Hyperkalemia may exhibit the following electrocardiographic abnormalities: disappearance of the P wave, widening and slurring of QRS complex, changes of the S-T segment, tall peaked T waves.

Dosage and administration

Usual dose range: 20 to 400 mEq daily.

Dosage adults

  • Serum potassium greater than 2.5 mEq per liter. Intravenous infusion, up to 200 mEq of potassium daily in a concentration less than 30 mEq per liter at a rate not exceeding 10 mEq per hour.
  • Serum potassium less than 2.0 mEq per liter. Intravenous infusion, up to 400 mEq of potassium daily in a concentration less than 30 mEq per liter at a rate not exceeding 40 mEq per hour.

Directions

The contents of 10mL or 20mL should be diluted to a total volume of 500 or 1000mL with dextrose 5% or other isotonic intravenous solution. The resultant solution should be administered slowly only by intravenous injection.

Storage

Store between (15°-30 °C).

Presentation

Latex-free Stoppers

Each 10mL vial contains 20 mEq (1.49 g) of potassium chloride.

Each 20mL vial contains 40 mEq (2.98 g) of potassium chloride.

If you want more information about Potassium Chloride for Injection Concentrate:

  • Visit Health Canada website (https://www.canada.ca/en/health-canada.html); the manufacturer’s website www.omegalaboratory.com, or by calling 1-800-363-0584.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

Omega Laboratories Limited

Montreal, Canada, H3M 3A2

Last Revised: August 7, 2018

Control Number: 211794

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00402206

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Potassium Chloride for Injection Concentrate

DIN 00402206
Schedule(s) ETHICAL
Active ingredient(s) Potassium chloride 20 mEq
Dosage form(s) Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. B Blood and blood forming organ drugs
    1. B05 Blood substitutes and perfusion solutions
      1. B05X I.V. solution additives
        1. B05XA Electrolyte solutions
          1. B05XA01 Potassium chloride
Company OMEGA LABORATORIES LIMITED
Current status Marketed
Current status date August 2, 2019

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.